Drug Shortage Report for TOBRAMYCIN INJECTION
| Report ID | 80604 |
| Drug Identification Number | 02230640 |
| Brand name | TOBRAMYCIN INJECTION |
| Common or Proper name | Tobramycin for Injection |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | TOBRAMYCIN |
| Strength(s) | 40MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 30 mL |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-04-08 |
| Actual start date | |
| Estimated end date | 2019-05-06 |
| Actual end date | 2019-05-10 |
| Shortage status | Resolved |
| Updated date | 2019-05-11 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2019-05-11 | English | Compare |
| v5 | 2019-05-10 | French | Compare |
| v4 | 2019-05-10 | English | Compare |
| v3 | 2019-04-09 | English | Compare |
| v2 | 2019-04-05 | French | Compare |
| v1 | 2019-04-05 | English | Compare |
Showing 1 to 6 of 6